Health And Medicine
-
Researchers track neuron branching’s genetic control switch
In an effort to understand how neurons develop different “architectures,” Vanderbilt developmental biologists have discovered a genetic switch that controls one type of neuron branching in the nematode worm. Read MoreAug 15, 2013
-
Oxidative stress in autism
A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care. Read MoreAug 14, 2013
-
Noninvasive test detects stomach bug
A noninvasive test can be used to identify the presence of Helicobacter pylori and evaluate its virulence, which will be useful in areas with high rates of H. pylori-associated gastric cancer. Read MoreAug 12, 2013
-
Nashville Scene Innovations 2013: In the Wake
A partnership with Vanderbilt University and Nashville-based Ingram Barge was formed in order to study sleep deprivation in Ingram’s employees and address the issues of pilot fatigue and public safety on the waterways. Patience Bridges, sleep program coordinator at the Vanderbilt Sleep Center, is quoted. Read MoreAug 9, 2013
-
‘Yo-yo dieting’ inflames fat tissue
Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone. Read MoreAug 9, 2013
-
Glasses bring girl’s world back in focus
Once upon a time, teenage girls were not clamoring to sport a pair of thick, black, oversized eyeglasses. Read MoreAug 8, 2013
-
Nuclear shield against cell death
The protein SARM appears to protect cells from inflammation-driven death by stabilizing the nuclear laminin scaffold. Read MoreAug 8, 2013
-
Vanderbilt scientists discover potential new way to treat anxiety
Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week. Read MoreAug 5, 2013
-
Cognitive complaints, Alzheimer’s risk studied
A study of cognitive complaints in older adults showed that memory concerns from both the patient and an informant was most predictive of converting to Alzheimer’s disease or dementia within three years. Read MoreAug 1, 2013
-
Study explores race differences of lung cancer risk
Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups. Read MoreAug 1, 2013
-
Case study explores stroke, meningitis link
A case series by researchers at Vanderbilt University Medical Center examines three patients transferred here with ischemic stroke who later received a diagnosis of fungal meningitis attributed to tainted injections for low back pain, part of a multi-state outbreak. Read MoreAug 1, 2013
-
Factor’s role in long bone development
Insight into how the protein neurofibromin participates in the signaling pathway that produces the body’s long bones has implications for fracture healing in some patients. Read MoreJul 31, 2013
-
Motor protein revs up cell division
A motor protein that helps drive cell division may be a promising new target for cancer therapeutics. Read MoreJul 29, 2013
-
Reducing fatal rhythms after heart attack
Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks. Read MoreJul 26, 2013
-
App helps children manage their health care routines
Adults have calendar applications on all their digital devices to remind them of appointments and what’s next on their agenda. Read MoreJul 25, 2013
-
Award bolsters study of bladder cancer chemo resistance
David DeGraff, Ph.D., has received the 2013 BCAN Young Investigator Award for Bladder Cancer Research. Read MoreJul 25, 2013
-
‘Bionic eye’ new option for retinitis pigmentosa patients
Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP). Read MoreJul 25, 2013
-
Pollen counts boost risk of rare drug reaction: study
High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found. Read MoreJul 25, 2013
-
Visualizing data on network ‘maps’
The new web application NetGestalt will allow investigators to simultaneously visualize different types of data for the same gene – such as mutation, expression and modification. Read MoreJul 25, 2013
-
Probing roles of a cell death protein
Vanderbilt researchers have discovered new roles for a protein involved in cell death processes that are activated to prevent tumor-causing DNA mutations. Read MoreJul 17, 2013